Eating disorders (EDs) include a range of chronic and disabling related psychiatric pathologies characterized by aberrant eating patterns or weight-control behavior and distorted body image. The etiology of EDs is complex and not yet completely understood. The endocannabinoid system has been widely reported to be involved in the regulation of feeding and energy balance, and cannabinoid type-1 receptors (CB1Rs) are expressed in many brain regions that control food intake. Animal and human studies indicate that CB1R agonists possess orexigenic effects enhancing appetite and increasing the perceived reward value of food. Conversely, CB1R antagonists have been shown to inhibit food intake. Previous clinical and preclinical evidence has led us to hypothesize a link between defects in the endocannabinoid system and EDs and supports the development of drugs that modulate this system in ED-related pathologies.

The endocannabinoid system: Anorexia nervosa and binge eating disorder

SCHERMA, MARIA;SATTA, VALENTINA;FRATTA, WALTER;FADDA, PAOLA
2015

Abstract

Eating disorders (EDs) include a range of chronic and disabling related psychiatric pathologies characterized by aberrant eating patterns or weight-control behavior and distorted body image. The etiology of EDs is complex and not yet completely understood. The endocannabinoid system has been widely reported to be involved in the regulation of feeding and energy balance, and cannabinoid type-1 receptors (CB1Rs) are expressed in many brain regions that control food intake. Animal and human studies indicate that CB1R agonists possess orexigenic effects enhancing appetite and increasing the perceived reward value of food. Conversely, CB1R antagonists have been shown to inhibit food intake. Previous clinical and preclinical evidence has led us to hypothesize a link between defects in the endocannabinoid system and EDs and supports the development of drugs that modulate this system in ED-related pathologies.
9780124171244
Anorexia nervosa; Binge eating disorder; Bulimia nervosa; Cannabinoid type-1 receptors; Eating disorders; Endocannabinoid system; Food intake; Obesity; Medicine (all)
File in questo prodotto:
File Dimensione Formato  
scherma et alCannabinoids in Neurologic and Mental Disease 2015.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 2.54 MB
Formato Adobe PDF
2.54 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11584/188593
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact